Purpose Uveal melanoma (UM) is adults' most common primary intraocular malignant tumor.
It has been observed that 40% of patients experience distant metastasis during subsequent …

Current immunotherapies are unsatisfactory against uveal melanoma (UM); however,
elevated CD8+ T cell infiltration level indicates poor prognosis in UM. Here, we aimed to …

Background CD8+ T cells work as a key effector of adaptive immunity and are closely
associated with immune response for killing tumor cells. It is crucial to understand the role of …

Tumor‐infiltrating immune cells are capable of effective cancer surveillance, and their
abundance is linked to better prognosis in numerous tumor types. However, in uveal …

Background Uveal melanoma (UM) is the most common primary intraocular malignancy in
adults. Many previous studies have demonstrated that the infiltrating of immune and stromal …

Background: Metastasis is a major cause of death in UM, highlighting the need to use highly
specific and sensitive prognostic markers to identify patients with a risk of developing …

Background Uveal melanoma (UM) is an aggressive intraocular malignant tumor. The
present study aimed to identify the key genes associated with UM metastasis and …

Background Although there has been some progress in the treatment of primary uveal
melanoma (UVM), distant metastasis remains the leading cause of death in patients …

Background Uveal melanoma (UM) is the most common primary intraocular malignancy with
a strong tendency to metastasize. The prognosis is poor once metastasis occurs. The …

Uveal melanoma (UM) is the most common primary intraocular malignant tumor in adults
and almost fifty percent of patients subsequently develop systemic metastases usually …